Next Generation News and Research

RSS

Contego Medical announces completion of $5.6 million Series B financing round

Contego Medical, the first and only provider of the Integrated Embolic Protection filter platform for angioplasty balloon and stent delivery catheters, announces the completion of a $5.6 million Series B financing round led by Hatteras Venture Partners, an early stage venture firm with a focus on medical devices, biopharmaceuticals, diagnostics and related opportunities in human medicine.

19 Apr 2015

Precision for Medicine announces acquisition of Precision Health Economics

Precision for Medicine, a specialized services company supporting next-generation approaches to drug development and commercialization, today announced the acquisition of Precision Health Economics.

16 Apr 2015

Research findings could bolster efforts to develop next gen of anti-viral treatments

A newly developed spectroscopy method is helping to clarify the poorly understood molecular process by which an anti-HIV drug induces lethal mutations in the virus's genetic material.

16 Apr 2015

WGU announces new scholarship opportunity for nursing students

Western Governors University has announced a new scholarship opportunity for nursing master's degree students honoring the leadership and healthcare career of outgoing American Organization of Nurse Executives President Linda Knodel.

16 Apr 2015

Innovative liver cancer treatment gets EU approval

A new treatment for liver cancer developed by the University Medical Center (UMC) Utrecht has received the European CE mark for quality and safety.

15 Apr 2015

Experts to make roadmap for future research, clinical trials for SCLC patients at IASLC workshop

Small cell lung cancer (SCLC) will be the concentrated focus when 100 global experts in the field meet for a workshop hosted by the International Association for the Study of Lung Cancer on April 22-24, 2015 at Memorial Sloan Kettering Cancer Center in New York City.

15 Apr 2015

New longer-term data on Genzyme's relapsing MS treatments to be presented at AAN 2015

Genzyme, a Sanofi company, announced today that new longer-term data on its relapsing multiple sclerosis treatments, Aubagio (teriflunomide) and Lemtrada (alemtuzumab), will be featured during the 67th annual meeting of the American Academy of Neurology being held in Washington, D.C. April 18-25.

15 Apr 2015

LABORIE completes acquisition of Medical Measurement Systems

LABORIE Medical Technologies has completed its acquisition of Medical Measurement Systems. MMS is headquartered in Enschede, The Netherlands, with a German subsidiary in Bottrop and US operations in Dover, New Hampshire.

13 Apr 2015

TGen scientists discover the likely cause of rare type of muscle weakness in six children

Scientists at the Translational Genomics Research Institute (TGen), using state-of-the-art genetic technology, have discovered the likely cause of a child's rare type of severe muscle weakness.

10 Apr 2015

Philips launches connected health technology solutions at HIMSS15

Royal Philips today announced its participation in the 2015 HIMSS Annual Conference & Exhibition (HIMSS15), taking place April 12-16 in Chicago, Ill.

10 Apr 2015

Clinical research studies improve medical care, allow access to new therapies

Clinical research studies are the reason medical care has improved leaps and bounds in the past few decades. Without these carefully-designed tests for new drugs, procedures or devices, treatments for diseases would not progress. These studies should be viewed as opportunities, although some people may view them negatively.

10 Apr 2015

New priority program set to develop next generation of optogenetic tools

Optogenetics is a new field of research that introduces light-sensitive proteins into cells in a genetically targeted manner, for example, to obtain information on signalling pathways and the function of neurons in a living organism.

10 Apr 2015

New, cross-sector collaboration aims to discover clinical biomarker for pancreatic cancer

The search to discover and validate the first-ever clinical biomarker to diagnose and treat pancreatic cancer is at the foundation of a new, cross-sector collaboration. Berg, a biopharmaceutical company committed to uncovering health solutions through a data-driven, biological research approach; the Cancer Center at Beth Israel Deaconess Medical Center, a Harvard Medical School teaching hospital, and the Pancreatic Cancer Research Team managed by Cancer Research And Biostatistics announced today they will work together to eradicate the disease.

9 Apr 2015

Liaison Technologies announces availability of Liaison Alloy Health Platform

Liaison Technologies, an industry-recognized leader in cloud-based integration and data management offerings, today announced the availability of the Liaison Alloy Health Platform, a next-generation platform for integrating and managing data across the increasingly interdependent domains of healthcare, health research, and life sciences.

9 Apr 2015

UTMB scientists develop quick-acting vaccine that is effective against Ebola strain

An interdisciplinary team from The University of Texas Medical Branch at Galveston and Profectus BioSciences, Inc. has developed a quick-acting vaccine that is both safe and effective with a single dose against the Ebola strain that killed thousands of people in West Africa last year.

8 Apr 2015

PAREXEL announces three new academic programs to develop global biopharmaceutical workforce

PAREXEL International Corporation, a leading global biopharmaceutical services provider, today announced three new academic programs at the PAREXEL Academy.

From Parexel 8 Apr 2015

U-M's Taubman Institute receives $3 million gift to support next generation of medical research

A $3 million gift from noted business and philanthropic leaders Leslie and Abigail Wexner will support the next generation of medical research trailblazers at the University of Michigan through grants from the A. Alfred Taubman Medical Research Institute.

6 Apr 2015

Next Generation News and Research

Contego Medical announces completion of $5.6 million Series B financing round

Precision for Medicine announces acquisition of Precision Health Economics

Research findings could bolster efforts to develop next gen of anti-viral treatments

WGU announces new scholarship opportunity for nursing students

Innovative liver cancer treatment gets EU approval

Experts to make roadmap for future research, clinical trials for SCLC patients at IASLC workshop

New longer-term data on Genzyme's relapsing MS treatments to be presented at AAN 2015

LABORIE completes acquisition of Medical Measurement Systems

TGen scientists discover the likely cause of rare type of muscle weakness in six children

Philips launches connected health technology solutions at HIMSS15

Clinical research studies improve medical care, allow access to new therapies

New priority program set to develop next generation of optogenetic tools

New, cross-sector collaboration aims to discover clinical biomarker for pancreatic cancer

Liaison Technologies announces availability of Liaison Alloy Health Platform

UTMB scientists develop quick-acting vaccine that is effective against Ebola strain

PAREXEL announces three new academic programs to develop global biopharmaceutical workforce

U-M's Taubman Institute receives $3 million gift to support next generation of medical research

eRelevance’s progressive patient engagement service sold to 100 Medspa, Plastic Surgery practices

Research may point to new paradigms in diagnosis, treatment of aggressive cancers

Registration opens for inaugural Stanford Medicine X|ED conference

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News